Overview
No overview information available.
Indication
主要用于敏感菌引起感染的治疗,如菌痢、肠炎、化脓性脑膜炎、扁桃体炎、外耳炎、蜂窝织炎及呼吸系统、泌尿系统的感染,也可用于疟疾的预防和治疗。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Sulfamonomethoxine Tablets | 国药准字H50020716 | 化学药品 | 片剂 | 7/13/2020 | |
Sulfamonomethoxine Tablets | 国药准字H43021599 | 化学药品 | 片剂 | 1/15/2020 | |
Sulfamonomethoxine Tablets | 国药准字H23020094 | 化学药品 | 片剂(素片) | 7/27/2020 | |
Sulfamonomethoxine Tablets | 国药准字H14022461 | 化学药品 | 片剂 | 4/10/2020 | |
Sulfamonomethoxine Tablets | 国药准字H11020372 | 化学药品 | 片剂 | 11/27/2020 | |
Sulfamonomethoxine Tablets | 国药准字H51022738 | 化学药品 | 片剂 | 11/18/2020 | |
Sulfamonomethoxine Tablets | 国药准字H41020570 | 化学药品 | 片剂 | 7/6/2020 | |
Sulfamonomethoxine Tablets | 国药准字H37020312 | 化学药品 | 片剂 | 3/11/2020 | |
Sulfamonomethoxine Tablets | 国药准字H41024280 | 化学药品 | 片剂 | 6/12/2020 | |
Sulfamonomethoxine Tablets | 国药准字H14021987 | 化学药品 | 片剂 | 4/20/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.